Hello, Fool! | Login | Signup | My Fool
Oct 15, 2008 7:32 PM ET | Feedback | Site Changes | Help
A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.
View All Commentary (MNTA)
Recs
PBrigg (97.56) Submitted: 6/27/07 2:01 PM : Start Price: $11.32 MNTA Score: 25.62
Why is this stock so low?!?! Way undervalued currently. Once they get FDA approval this stock is gonna be rockin. Definitely outperforming the S&P.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK